BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 27147489)

  • 1. The Hippo pathway in intestinal regeneration and disease.
    Hong AW; Meng Z; Guan KL
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
    Kodaka M; Hata Y
    Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP and TAZ Take Center Stage in Cancer.
    Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
    Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
    Patel SH; Camargo FD; Yimlamai D
    Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway in tissue homeostasis and regeneration.
    Wang Y; Yu A; Yu FX
    Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation and function of YAP transcription co-activator.
    Zhu C; Li L; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between Hippo signalling and miRNAs in tumour progression.
    Li N; Xie C; Lu N
    FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo pathway regulation of gastrointestinal tissues.
    Yu FX; Meng Z; Plouffe SW; Guan KL
    Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.
    Zhou X; Wang Z; Huang W; Lei QY
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):10-5. PubMed ID: 25491506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
    Ma Y; Yang Y; Wang F; Wei Q; Qin H
    Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue.
    Li N; Lu N; Xie C
    FEBS J; 2019 Oct; 286(19):3745-3756. PubMed ID: 31342636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of signaling pathways regulating YAP/TAZ activity.
    Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X
    Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
    Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.